The best of R&I and around the web, handpicked by our editors.
White papers, service directory and conferences for the R&I community.
Web replica of the print magazine.
Enlyte’s Nikki Wilson offers a fresh take on a promising alternative to opioids, a first-of-its-kind FDA-approved non-addictive medication for pain.
We highlighted these sessions for today’s NWCDC attendees.
A progressive goal attainment program can help injured workers overcome psychosocial risk factors.
Models analyze variables at intake and afterward to identify claims that may become adverse.
Boeing is innovating to improve both its workers’ comp outcomes and the quality of health care delivered to its workers.
Quality assurance programs prevent talented claims adjusters and supervisors from jumping ship.
Technology is helping to transform medical services, but employers and providers need to focus more on socioeconomic factors.
Tested solutions for the toughest challenges.
Teddy Award winners will be honored on Thursday at “Steal These Ideas! Award-Winning Employers Share Their Successes,” beginning at 8:30 a.m.
The Theodore Roosevelt Workers’ Compensation and Disability Management Award honors exceptional programs that innovate to produce the best results.
Despite ongoing controversy, the New Mexico Workers’ Compensation Administration is attempting to provide reimbursement guidance on medical marijuana.
Pharmacy benefit managers are becoming a greater force in clinical case management, adapting to higher customer expectations.
NCCI’s latest findings reinforce the assertion that there are adverse effects when Rx fee schedules are set too high.
Sophisticated pharmacy data allows workers’ comp payers to spot utilization red flags.
Spending on prescription drugs accounts for a large share of workers’ comp medical costs, but utilization can be controlled.
With California’s closed drug formulary nearly a done deal, other states including Tennessee and Louisiana are exploring the idea.
A new study found that back fusion patients fared significantly worse when receiving long-term opioid therapy.
Studies have identified strong evidence that California’s SB 863 reforms are positively impacting workers’ comp costs.
Payers are increasingly being held responsible for addiction and overdoses related to opioid pain medications prescribed for occupational injuries.